Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
For more information about the trial above please contact the study team:
Principal Investigator, John Wrangle, at email@example.com.
Study Coordinator, Alexandra Leitner, at firstname.lastname@example.org, or please call +1 843-792-1507.
Trial opened at the following institutions: Medical University of South Carolina